We're excited to announce that From Ideas to Innovation will be back in 2026!

  • Wednesday 15 and Thursday 16 April
  • 30 Euston Square, London, NW1 2FB

From Ideas to Innovation, 15-16 April 2026.  30 Euston Square, London.

What is From Ideas to Innovation?

Our biennial research conference brings prostate cancer researchers together to hear the latest research updates, network, develop collaborations, and hear inspiring stories from men affected by prostate cancer and their families - our Patient Research Partners.

202404 Ideas To Innovation Research Event Rosie Lonsdale 200
202404 Ideas To Innovation Research Event Rosie Lonsdale 158

Registration - reserve list!

All places to attend From Ideas to Innovation have now been filled. You can register your details on our reserve list, and if a place become available we'll contact you to let you know.

Register for the reserve list

To ensure you don’t miss any updates on our upcoming research events, subscribe to the research newsletter and follow us on Bluesky or X (Twitter).

"I loved to see that patients have been invited to share their stories. There was a wide range of topics and lots of time for networking. I found the whole atmosphere very friendly and I felt very welcomed."
Attendee

A meeting for researchers designed by researchers

From Ideas to Innovation is co-designed with our fantastic Scientific Organising Committee to help ensure the event meets the research community's needs.

Scientific Organising Committee

202404 Ideas To Innovation Research Event Rosie Lonsdale 88
202404 Ideas To Innovation Research Event Rosie Lonsdale 14

Day 1 Agenda: Wednesday 15 April 2026

Sessions and Speakers for Day 1 of From Ideas to Innovation

We may update the agenda with minor changes, a final programme will be sent to delegates in advance of the event.

Registration will be held at 30 Euston Square, London, NW1 2FB, United Kingdom.

Refreshments and snacks will be provided.

Dr Matt Hobbs, Director of Research, Prostate Cancer UK

Session Chair:

Dr Jane Shortall, University of Manchester.

 

Transformational Impact Award:

Targeting CXCR1 and CXCR2 blockade to maximise clearance of myeloid cells from advanced prostate cancer and reverse resistance to therapy.

Mr Simon Aylett, Patient Research Partner.
Professor Johann de Bono, The Institute of Cancer Research.
Dr Alec Paschalis, The Institute of Cancer Research.

 

Research Snapshots:

Dr Mark Linch, University College London.
Dr Pochuan Chiu, Imperial College London.
Dr Caroline Dalgliesh, Newcastle University.
Dr Ralf Zwacka, University of Essex.

Drinks and snacks will be provided.

Session Chair:

Dr Koichi Sasaki, Imperial College London.

 

Transformational Impact Award:

Leveraging Pan Prostate Cancer Group (PPCG) Resources for Predicting Prostate Cancer Outcome and to Facilitate Cancer Prevention.

Mr Robin Porter, Patient Research Partner.
Professor Colin Cooper
, University of East Anglia.
Dr Harveer Dev, University of Cambridge.

 

Research Snapshots:

Professor Ananya Choudhury, University of Manchester.
Professor Aled Clayton, Cardiff University.
Dr Demi Pritchard, Swansea University.
Dr Srinivasa Rao, University of Oxford.

Sandwiches, finger food and refreshments will be provided.

Poster presenters will be with their posters from 1.15pm.

Session Chair:

Dr Sarah Gosling, Keele University.

 

Major Award:

A randomised controlled trial to assess screening for prostate cancer compared to current standard of care.

Ms Sue Duncombe, Patient Research Partner.
Professor Rakesh Heer, Imperial College London.
Professor Rhian Gabe, Queen Mary University of London.
Dr Nikhil Mayor, Imperial College London.

Session Chair:

Helen Eugene, Head of Equality, Diversity and Inclusion, Prostate Cancer UK.

 

Discussion:

From Conversation to Commitment: Equity in Research Career Progression.

Panel:

Dr Uzoamaka Okoli, University College London.
Manuella Siaka with Dr Emma Scott, Newcastle University.

Drinks and snacks will be provided.

Session Chair:

Dr Adriana Buskin, Newcastle University.

 

Transformational Impact Award:

A randomised controlled trial to assess the clinical and cost-effectiveness of PSMA PET imaging to stage newly diagnosed high risk prostate cancer.

Mr Robert Oldroyd, Patient Research Partner.
Professor Hashim Ahmed
, Imperial College London.
Dr Martin Connor, Imperial College London.

 

Research Snapshots:

Professor Anne Kiltie, University of Aberdeen.
Dr Debbie Moss, Queen's University Belfast.
Dr Boris Tocco, Kings College London.
Dr Zhuolin Yang, University of Edinburgh.

Networking opportunity.

Day 2 Agenda: Thursday 16 April 2026

Sessions and Speakers for Day 2 of From Ideas to Innovation

We may update the agenda with minor changes, a final programme will be sent to delegates in advance of the event.

Networking opportunity.

Dr Matt Hobbs, Director of Research, Prostate Cancer UK

Session Chair:

Dr Rayzel Fernandes, Imperial College London.

 

Transformational Impact Award:

Investigating the tumour microenvironment of high-risk localised prostate cancer to identify actionable pathways involved in cancer.

TBC, Patient Research Partner.
Professor Hing Leung
, University of Glasgow & CRUK Scotland Institute.
Dr Ed Roberts, University of Glasgow & CRUK Scotland Institute.

 

Research Snapshots:

Dr Natalie Bevan, Queen Mary University of London.
Dr Damien Leach, Imperial College London.
Dr Helen Pearson, Cardiff University.
Dr Nina Tunariu, The Institute of Cancer Research.

Drinks and snacks will be provided.

Session Chair:

Dr Corinne Woodcock, University of Nottingham.

 

Transformational Impact Award:

Understanding the Abscopal effect in Prostate Cancer – Primary and Metastatic Tumour Crosstalk

Mr Derek Price, Patient Research Partner.
Professor Charlotte Bevan
, Imperial College London.
Early Career Researcher (TBC), Imperial College London.

 

Research Snapshots:

Dr Eleanor Bellow, University of Nottingham.
Dr Marco Bezzi, The Institute of Cancer Research.
Jess Peng, Newcastle University.
Dr Gareth Richards, University of Sheffield.

Sandwiches, finger food and refreshments will be provided.

Poster presenters will be with their posters from 1.15pm.

Simon Grieveson, Assistant Director of Research, Prostate Cancer UK

Dr Hayley Luxton, Head of Research Impact and Engagement, Prostate Cancer UK

Session Chair:

Dr Ahmet Hazini, University of Oxford.

 

Transformational Impact Award:

STOPCAP 2 - Maximising patient benefit through enhanced evaluation of therapies and better characterisation of metastatic hormone-sensitive prostate cancer

Dr David Matheson, Patient Research Partner.
Professor Jayne Tierney
, University College London.
Dr Hannah Rush, University College London.
Dr Annabelle South, University College London.

 

Research Snapshots:

Cameron Alexander, University of Manchester.
Dr Kelly Coffey, Newcastle University.
Dr Chun Fui Lai, Imperial College London.
Dr Melissa LaBonte Wilson, Queen's University Belfast.

Drinks and snacks will be provided.

Session Chair:

Dr Emma Lishman-Walker, Newcastle University.

 

Transformational Impact Award:

STAMPEDE Life: Temporal-spatial resolution of prostate cancer evolution to a lethal hormone and radioligand therapy resistant phenotype in metastatic patients randomised in the STAMPEDE2 trial

Dr Patrick Williams, Patient Research Partner.
Professor Gert Attard
, University College London.
Dr Ashwin Sachdeva, University of Manchester.
Dr Emily Grist, University College London.

 

Research Snapshots:

Professor Ian Mills, University of Oxford.
Professor Francesco Crea, Open University.
Dr James Hindley, Kings College London.
Dr Nicola Annels, University of Surrey.

Laura Kerby: CEO, Prostate Cancer UK

Frequently Asked Questions

Who can attend From Ideas to Innovation?

Any researcher, from any stage of their career is welcome to attend. You don't have to be funded by Prostate Cancer UK.

All places to attend are now full - please register to be added to the reserve list and we'll contact you if a place becomes available.

Can I present my work?

We've been delighted by the strong interest in presenting posters at the event, and all presentation slots are now filled. If you've already indicated via the registration form that you'd like to present a poster, we'll get in touch later in the year with more details.

Speakers at Ideas to Innovation are by invitation. If you're an early career researcher, you'll be able to apply for a speaking slot at the next Making Progress event.

Is there a registration fee?

Prostate Cancer UK is covering the costs of running the event to keep the event free for researchers.

Will you cover travel costs for presenters?

We're able to cover reasonable travel costs for invited speakers. We'll give you more information on booking travel in early 2026.

Will you cover travel costs for attendees?

You may be able to cover travel costs from your Prostate Cancer UK grant budget. Check with the grant holder if conference costs were included in the award and confirm with them if there is money available in the conference budget for your 'From Ideas to Innovation' travel costs. Please then email [email protected], copying in the grant holder and quoting the grant reference, and we’ll confirm whether the costs can be charged. We’re sorry, but you won't be able to claim the travel costs of team members who are not directly employed on the grant.

Please register early and book any travel and accommodation as soon as possible to take advantage of lower prices.

If the cost of travel prevents you from attending From Ideas to Innovation, there will be a limited number of travel bursaries available.

  • You may be able to cover travel costs from your Prostate Cancer UK grant budget. Before applying for a bursary, please check with the grant holder if conference costs were included in the award and confirm with them if there is money available in the conference budget for your 'From Ideas to Innovation' travel costs. Please then email [email protected], copying in the grant holder and quoting the grant reference, and we’ll confirm whether the costs can be charged. We’re sorry, but you won't be able to claim the travel costs of team members who are not directly employed on the grant.
  • Before applying for a bursary, researchers must seek funding for travel costs from their own institution and should only apply for the bursary if they have exhausted all other funding options. We’ll require proof that funds are not available elsewhere as part of the application e.g. an email from your principal investigator / institution.
  • If a travel bursary is awarded, Prostate Cancer UK will book suitable travel in liaison with the researcher. There will be no transfer of money to the researcher.
  • We're not able to cover travel costs from outside of the UK.
  • So that we can support as many researchers as possible, we’ll book the most economic form and times of travel e.g. making bookings as soon as train tickets become available and avoiding rush hour prices. We won’t be able to reimburse driving costs.
  • It’s unlikely that we’ll be able to fund applicants who are travelling from the London area, and priority will be given to applicants who will be travelling for more than an hour.
  • We’re not able to cover accommodation costs at this time.
  • Applications will be considered on a first come first served basis. We aim to let you know the outcome of your application within approximately two weeks. We have limited funds available and once these funds are allocated, the bursary will close for applications.

To be considered for a travel bursary, please submit this application form. If you have any questions, please contact [email protected]